🔴 Amgen is trading 5% down in pre-market amid global risk-off trading

Amgen is trading 5.11% down at $414.88 after broad pre-market weakness, with the decline primarily reflecting global risk-off trading.

• The Dow is down 0.93%, S&P 500 down 0.43%, and Nasdaq down 0.22%.
• No clear negative company-specific announcement was found for September 8, 2026.
• Wells Fargo recently raised its price target to $435 while maintaining a Neutral rating.